Gabapentinoid Polypharmacy Among Medicare Beneficiaries During the Poststroke Recovery Period
Health Services Research · 2026-06 · 61 (3)
DOI: 10.1111/1475-6773.70133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Services Research, online erschienen am 20.05.2026. Verfasst von Julianne D Brooks und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Medicare, Gabapentin, Polypharmacy, Stroke. Die Arbeit nennt 44 Literaturangaben. Gefördert von: NIA NIH HHS, NIH HHS, National Institutes of Health.
Themen: Medikationssicherheit
Abstract (Originalsprache)
Objective
To describe patterns of gabapentinoid (Gabapentin and Pregabalin) use and concurrent use with other central nervous system (CNS) acting pain medications (opioids and benzodiazepines) among US Medicare beneficiaries following acute ischemic stroke (AIS). Study Setting and Design We analyzed new outpatient gabapentinoid prescriptions in older stroke survivors between 2009 and 2022. We calculated the percent of new gabapentinoid initiators within 6 months of stroke discharge and analyzed concurrent pain medications prescribed within 30 days of gabapentinoid initiation. We presented trends and geographic patterns standardized by age, discharge destination, and modified Rankin Scale (mRS) to control for variations in the sample composition by age and stroke severity over time. Data Sources and Analytic Sample We analyzed a 20% sample of US Medicare beneficiaries aged 65 years or older who were hospitalized for AIS. We included those who met Medicare enrollment criteria, had no prior stroke, no prior gabapentinoid use within 6 months, and were discharged home within 30 days of hospitalization. Principal Findings Among 153,728 stroke survivors, 4.9% received new gabapentinoid prescriptions within 6 months postdischarge. Of the 7595 gabapentinoid initiators, 1579 (21%) had concurrent opioid and 653 (8.6%) had concurrent benzodiazepine prescriptions. In the sample, the median age was 78 years (Quartile Range: 72–84), 55% were female, and 81% were non‐Hispanic White. The standardized percentage of gabapentinoid initiators increased from 3.8% in 2009 to 5.9% in 2022 (crude: 3.6% in 2009 to 5.8% in 2022). Despite increases in the number of gabapentinoid initiators, the percentage of concurrent opioid users remained low over time, around 1% of the study population. We observed variation in gabapentinoid initiation and concurrent use with opioids by geography.
Conclusions
From 2009 to 2022, poststroke gabapentinoid use increased in older adults, but concurrent use with opioids remained low over time.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
- Harvard Kennedy School, Cambridge, Massachusetts, USA.
- National Bureau of Economic Research, Cambridge, Massachusetts, USA.
ORCID-Profile: Julianne D Brooks, Rebeka Bustamante Rocha, Maria A Donahue, Joseph P Newhouse, Alexander C Tsai, Lidia M V R Moura
Förderung
- NIA NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Brooks, J. D., Rocha, R. B., Donahue, M. A., Newhouse, J. P., Haneuse, S., Tsai, A. C., & Moura, L. M. V. R. (2026). Gabapentinoid Polypharmacy Among Medicare Beneficiaries During the Poststroke Recovery Period. Health Services Research, 61(3). https://doi.org/10.1111/1475-6773.70133
Vancouver
Brooks JD, Rocha RB, Donahue MA, Newhouse JP, Haneuse S, Tsai AC, et al. Gabapentinoid Polypharmacy Among Medicare Beneficiaries During the Poststroke Recovery Period. Health Services Research. 2026;61(3). doi:10.1111/1475-6773.70133
BibTeX
@article{Brooks2026,
author = {Brooks, Julianne D and Rocha, Rebeka Bustamante and Donahue, Maria A and Newhouse, Joseph P and Haneuse, Sebastien and Tsai, Alexander C and Moura, Lidia M V R},
title = {Gabapentinoid Polypharmacy Among Medicare Beneficiaries During the Poststroke Recovery Period},
journal = {Health Services Research},
year = {2026},
volume = {61},
number = {3},
doi = {10.1111/1475-6773.70133}
}
EUVIMED